(Q61955477)
Statements
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus (English)
0 references
November 2011
0 references
October 2013
0 references
465
0 references
18 year
0 references
75 year
0 references